Abstract
Oral administration of L-tryptophan to rats produced two main biochemical and pharmacological effects: a marked increase in urinary 5-hydroxyindoleacetic acid excretion, and a significant reduction in the urine flow after a water load. Urinary 5-hydroxyindoleacetic acid excretion reached its maximum 2 to 6 hr after the administration of tryptophan, and it increased with the dose of the amino acid. Antidiuresis was seen after the administration of L-tryptophan, 200 mg/kg, or more. The effect appeared promptly and it was roughly proportional to the dose of the amino acid administered. Both antidiuretic effect and increase in urinary 5-hydroxyindoleacetic acid excretion were more intense after oral than after parenteral administration of L-tryptophan. D-Tryptophan, in oral doses up to 1,000 mg/kg, produced neither an increase in urinary 5-hydroxyindoleacetic acid nor a reduction of diuresis. Available evidence suggests that reduction of urine flow is a consequence of biosynthesis and release of 5-hydroxytryptamine by the gastrointestinal mucosa. Tryptamine produced by direct decarboxylation of L-tryptophan does not seem to play any important role.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bertaccini G. Tissue 5-hydroxytryptamine and urinary 5-hydroxyindoleacetic acid after partial or total removal of the gastro-intestinal tract in the rat. J Physiol. 1960 Sep;153(2):239–249. doi: 10.1113/jphysiol.1960.sp006532. [DOI] [PMC free article] [PubMed] [Google Scholar]
- ERSPAMER V. Observations on the fate of indolalkylamines in the organism. J Physiol. 1955 Jan 28;127(1):118–133. doi: 10.1113/jphysiol.1955.sp005242. [DOI] [PMC free article] [PubMed] [Google Scholar]
- ERSPAMER V. Pharmacology of indole-alkylamines. Pharmacol Rev. 1954 Dec;6(4):425–487. [PubMed] [Google Scholar]
- ERSPAMER V., TESTINI A. Observations on the release and turnover rate of 5-hydroxytryptamine in the gastrointestinal tract. J Pharm Pharmacol. 1959 Oct;11:618–623. doi: 10.1111/j.2042-7158.1959.tb12603.x. [DOI] [PubMed] [Google Scholar]
- KOPIN I. J. Tryptophan loading and excretion of 5-hydroxyindoleacetic acid in normal and schizophrenic subjects. Science. 1959 Mar 27;129(3352):835–836. doi: 10.1126/science.129.3352.835-a. [DOI] [PubMed] [Google Scholar]
- LAUER J. W., INSKIP W. M., BERNSOHN J., ZELLER E. A. Observations of schizophrenic patients after iproniazid and tryptophan. AMA Arch Neurol Psychiatry. 1958 Jul;80(1):122–130. doi: 10.1001/archneurpsyc.1958.02340070140021. [DOI] [PubMed] [Google Scholar]
- MACFARLANE P. S., DALGLIESH C. E., DUTTON R. W., LENNOX B., NYHUS L. M., SMITH A. N. Endocrine aspects of argentaffinoma, with special reference to the use of urinary 5-hydroxyindoleacetic acid estimations in diagnosis. Scott Med J. 1956 Apr;1(4):148–155. doi: 10.1177/003693305600100402. [DOI] [PubMed] [Google Scholar]